Review decisions

Showing 130 results of 820 total
Regulatory Decision Summary for Vaxneuvance
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00899
Product Type: Drug
Control Number: 247042
DIN(s): 02522403
Manufacturer: Merck Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-12-04
Decision / Authorization Date: 2021-11-16
Regulatory Decision Summary for Camcevi
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01036
Product Type: Drug
Control Number: 246800
DIN(s): 02522446
Manufacturer: Accord Healthcare Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-12-07
Decision / Authorization Date: 2021-11-16
Regulatory Decision Summary for Glassia
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1685714954062
Product Type: Drug
Control Number: 246730
DIN(s): 02522438
Manufacturer: Takeda Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-11-24
Decision / Authorization Date: 2021-11-12
Regulatory Decision Summary for Nexviazyme
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00891
Product Type: Drug
Control Number: 245680
DIN(s): 02522365
Manufacturer: Sanofi-Aventis Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-10-26
Decision / Authorization Date: 2021-11-12
Summary Basis of Decision for Retevmo
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00555
Product Type: Drug
Control Number: 243748
DIN(s): 02516918, 02516926
Manufacturer: Loxo Oncology, Inc.
Submission Type: New Drug Submission
Issued / Original Publication Date: 2021-11-09
Regulatory Decision Summary for Abevmy
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00888
Product Type: Drug
Control Number: 237499
DIN(s): 02522160, 02522179
Manufacturer: BGP Pharma ULC
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-06-07
Decision / Authorization Date: 2021-11-05
Regulatory Decision Summary for Padcev
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00885
Product Type: Drug
Control Number: 251438
DIN(s): 02521903, 02521911
Manufacturer: Seagen Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-04-06
Decision / Authorization Date: 2021-10-29
Regulatory Decision Summary for Ngenla
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00894
Product Type: Drug
Control Number: 246729
DIN(s): 02521679, 02521687
Manufacturer: Pfizer Canada ULC., on behalf of BioNTech Manufacturing GmbH
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-11-24
Decision / Authorization Date: 2021-10-26
Regulatory Decision Summary for JAMP GOSERELIN LA
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01085
Product Type: Drug
Control Number: 232286
Manufacturer: JAMP Pharma Corporation
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-04-14
Decision / Authorization Date: 2021-10-20
Regulatory Decision Summary for Opsynvi
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00995
Product Type: Drug
Control Number: 245848
DIN(s): 02521083
Manufacturer: Janssen Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-10-29
Decision / Authorization Date: 2021-10-14

Displaying 121 - 130 of 820 | Page 13 of 82
Report a problem or mistake on this page
Please select all that apply:
Date modified: